Catalyst Wire Dossier Catalyst Wire Dossier

Lentiviral gene therapy for CGD

Lentiviral gene therapy · Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lentiviral gene therapy for CGD, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Lentiviral Gene Therapy for CGD [NA]

See pricing